Document Detail


MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.
MedLine Citation:
PMID:  16636248     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with recurrent gliomas (n = 14) were treated with bevacizumab and carboplatin, cpt-11, or etoposide. Follow-up MRI scans were obtained 2 to 6 weeks after initiation of treatment. Contrast-enhancing tumor shrank in 7 patients, with reductions evident in as little as 2 weeks after initiation of therapy. Treatment seemed more effective for heterogeneously enhancing tumor compared with solidly enhancing tumor.
Authors:
W B Pope; A Lai; P Nghiemphu; P Mischel; T F Cloughesy
Related Documents :
19060598 - Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
18769928 - Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in c...
8323768 - Prognostic factors in malignant gliomas with special reference to intra-arterial chemot...
19520698 - Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy ...
10814918 - Long-term results of sleeve lobectomy for lung cancer.
18829088 - Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovari...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurology     Volume:  66     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-04-25     Completed Date:  2006-06-05     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1258-60     Citation Subset:  AIM; IM    
Affiliation:
Department of Radiological Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. wpope@mednet.ucla.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Camptothecin / analogs & derivatives,  therapeutic use
Carboplatin / therapeutic use
Drug Therapy, Combination
Etoposide / therapeutic use
Female
Glioma / drug therapy,  pathology*,  therapy*
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy,  therapy
Vascular Endothelial Growth Factor A / antagonists & inhibitors,  immunology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Humanized; 0/Vascular Endothelial Growth Factor A; 2S9ZZM9Q9V/bevacizumab; 33419-42-0/Etoposide; 41575-94-4/Carboplatin; 7673326042/irinotecan; 7689-03-4/Camptothecin
Comments/Corrections
Comment In:
Neurology. 2006 Dec 12;67(11):2089; author reply 2089   [PMID:  17159134 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection.
Next Document:  Nonconvulsive status epilepticus in metastatic CNS disease.